These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 26743551)

  • 1. [Issues in need for a solution among patients with successful eradication of hepatitis C virus].
    Kurosaki M; Izumi N
    Nihon Shokakibyo Gakkai Zasshi; 2016; 113(1):29-35. PubMed ID: 26743551
    [No Abstract]   [Full Text] [Related]  

  • 2. The Road to Hepatitis C Virus Cure: Practical Considerations from a Health System's Perspective.
    Jonas MC; Loftus B; Horberg MA
    Infect Dis Clin North Am; 2018 Jun; 32(2):481-493. PubMed ID: 29778267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Liver Cancer Emergence Associated with Antiviral Treatment: An Immune Surveillance Failure?
    Reig M; Boix L; Mariño Z; Torres F; Forns X; Bruix J
    Semin Liver Dis; 2017 May; 37(2):109-118. PubMed ID: 28388736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Viral hepatitis at a crossroad.
    Lok AS; Pawlotsky JM
    Gastroenterology; 2012 May; 142(6):1261-3. PubMed ID: 22537431
    [No Abstract]   [Full Text] [Related]  

  • 5. Hepatitis C virus elimination: laying the foundation for achieving 2030 targets.
    Dore GJ; Bajis S
    Nat Rev Gastroenterol Hepatol; 2021 Feb; 18(2):91-92. PubMed ID: 33257831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pretreatment Lesions on Magnetic Resonance Imaging in Patients With Hepatitis C Virus Infection Diagnosed With Hepatocellular Carcinoma After Initiating Direct-Acting Antiviral Therapy.
    Scott RA; Aithal GP; Francis ST; Irving WL
    Gastroenterology; 2018 May; 154(6):1848-1850. PubMed ID: 29621514
    [No Abstract]   [Full Text] [Related]  

  • 7. Strategies to Reduce Hepatitis C Virus Reinfection in People Who Inject Drugs.
    Martinello M; Dore GJ; Matthews GV; Grebely J
    Infect Dis Clin North Am; 2018 Jun; 32(2):371-393. PubMed ID: 29778261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent advances in the prevention of hepatocellular carcinoma recurrence.
    Lu LC; Cheng AL; Poon RT
    Semin Liver Dis; 2014 Nov; 34(4):427-34. PubMed ID: 25369304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is hepatitis C virus eradication around the corner only 25 years after its discovery?
    Ippolito G; Capobianchi MR; Lanini S; Antonelli G
    Int J Antimicrob Agents; 2015 Feb; 45(2):111-2. PubMed ID: 25249016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal duration of pre-liver transplantation anti-hepatitis C virus treatment with direct-acting agent sofosbuvir.
    Borentain P; Colson P; Darque A; Gérolami R
    Liver Int; 2015 Jun; 35(6):1776. PubMed ID: 25619265
    [No Abstract]   [Full Text] [Related]  

  • 11. Infections and organ transplantation: new challenges for prevention and treatment of hepatitis C virus.
    Burra P; De Martin E
    Transplant Proc; 2011; 43(6):2455-6. PubMed ID: 21839292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.
    AASLD/IDSA HCV Guidance Panel
    Hepatology; 2015 Sep; 62(3):932-54. PubMed ID: 26111063
    [No Abstract]   [Full Text] [Related]  

  • 13. Low hepatitis C viral load predicts better long-term outcomes in patients undergoing resection of hepatocellular carcinoma irrespective of serologic eradication of hepatitis C virus.
    Shindoh J; Hasegawa K; Matsuyama Y; Inoue Y; Ishizawa T; Aoki T; Sakamoto Y; Sugawara Y; Makuuchi M; Kokudo N
    J Clin Oncol; 2013 Feb; 31(6):766-73. PubMed ID: 23129744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatitis C: Is eradication possible?
    Lombardi A; Mondelli MU;
    Liver Int; 2019 Mar; 39(3):416-426. PubMed ID: 30472772
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus 1b, cirrhosis, and hepatocellular carcinoma.
    Brechot C
    Hepatology; 1997 Mar; 25(3):772-4. PubMed ID: 9049234
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of adjuvant interferon therapy on hepatitis b/c virus-related hepatocellular carcinoma after curative therapy - meta-analysis.
    Xu J; Li J; Chen J; Liu ZJ
    Adv Clin Exp Med; 2015; 24(2):331-40. PubMed ID: 25931368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antiviral treatment of hepatitis C virus infection].
    Silvain C
    Rev Med Interne; 1999 Aug; 20 Suppl 3():331s-340s. PubMed ID: 10480183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of hepatocellular carcinoma after clearance of hepatitis C virus with interferon therapy.
    Tong MJ; Lai LP; Murakami-Mori K
    West J Med; 1997 Aug; 167(2):103-5. PubMed ID: 9291751
    [No Abstract]   [Full Text] [Related]  

  • 19. [Guidelines for the prevention and treatment of hepatitis C (2019 version)].
    ;
    Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):962-979. PubMed ID: 31941258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis C: the next 25years.
    Houghton M
    Antiviral Res; 2014 Oct; 110():77-8. PubMed ID: 25043637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.